Drug access gets a makeover as EVERSANA and Waltz Health combine forces
The healthcare industry is abuzz with the recent merger of EVERSANA and Waltz Health, two leading players in the pharmaceutical sector. This newly formed platform is actively hiring, offering exciting opportunities for those looking to make a difference in the industry.
EVERSANA, a renowned provider of end-to-end commercialization services to the top 50 pharma and biotech companies, has joined forces with Waltz Health, a pioneer in payer connectivity and drug affordability solutions. The combined company aims to redefine pharmaceutical commercialization and patient access, promising a transformative impact on the healthcare system.
The merged platform will operate using a software-powered drug-price marketplace and a direct-to-payer model. This innovative approach is expected to streamline drug access and lower costs by connecting patients, payers, and pharmaceutical companies.
Waltz Health, a company that contributes digital technology solutions, including AI-powered prescription routing and affordability tools, brings a unique expertise to the table. The job openings at Waltz Health might be related to these digital technology solutions or other areas of the merged healthcare platform.
The new model will focus on improving access to high-cost therapies, particularly specialty medications. This could potentially mean job openings for roles that focus on improving access to high-cost therapies or specialty medications. The job openings at Waltz Health could also be for roles that aim to drive significant cost savings and enhance patient outcomes across the healthcare system.
Interested candidates can view the job openings on the related resources section. Currently, there is one job opening available at Waltz Health in Chicago. The job openings at Waltz Health might involve working with the software-powered drug-price marketplace and the direct-to-payer model.
Steve Hoogendoorn, the new CEO of the merged company, is poised to lead this revolutionary venture. The new platform is expected to drive significant cost savings and enhance patient outcomes across the healthcare system, redefining the approach to drug access and value in the U.S. healthcare system.
This merger marks a significant step forward in the pharmaceutical industry, promising a more efficient, affordable, and accessible healthcare system for all.
Read also:
- EA Relies on Madden and Battlefield to Drive Microtransactions Recovery
- Expense for Creating a Digital Platform for Fantasy Sports
- Comprehensive Guide on Electric Vehicle Infotainment: Nearly all the essential insights about in-car entertainment systems in electric vehicles
- Strengthening Defense against Multi-faceted menaces in the Age of Authority-driven Technology
